A Foodie’s First-In-Class FDA Approval

Emily BurkeFDA, GMO, The WEEKLY

GMOs Finally Swim Upstream AquaBounty’s genetically modified salmon will make it to your dinner table in less time than it took to toil through the FDA pipeline. Coined AquAdvantage Salmon, it is the first genetically modified animal available for human consumption thanks to an approval last month. The two year wait time to grow the first batch pales in comparison … Read More

Catching The First Drop Of Cancer

Emily BurkeCancer, Deoxyribonucleic Acid (DNA), Diagnostics, FDA, Monoclonal Antibodies, Ribonucleic Acid (RNA), Term of the Week, The WEEKLY

The Latest In Cancer Diagnostics Hearing the words “it might be cancer” paired with your doctor’s perplexed look is enough to send shockwaves through your body. Getting to the heart of a diagnosis usually requires a surgical biopsy—removal and examination of the suspected tissue for visible signs of cancer. Less invasive diagnostic tests—called liquid biopsies—might just bring more choices to … Read More

The Uber Of The Human Body?

Emily BurkeBiologics, Business of Biotech, Cancer, Cardiovascular Disease, Deoxyribonucleic Acid (DNA), Drug Development, Drug Targets, Mechanism of Action, Ribonucleic Acid (RNA), Term of the Week, The WEEKLY

A Tiny Vesicle With Big Potential Cambridge-based startup Codiak BioSciences made headlines last month with $40M launch funding and another $40M if their technology shows promise. So, what’s the big deal? A tiny little particle—once described as a cellular trash truck—called the exosome. First observed in the early 1980s, exosomes were originally thought to be a way for cells to get rid of … Read More